AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimytime MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Vesla Life Sciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimytime MV 1mg/500mg/0.2mg Tablet

Diabetic patients may benefit from the anti-diabetic medication, Glimepiride/Metformin/Pioglitazone 1mg/500mg/0.2mg tablets, a combination therapy for type 2 diabetes in adults. This medication helps regulate blood glucose levels. Administer this medicine with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and might be adjusted based on blood sugar monitoring. Continue this treatment as prescribed, even if feeling well or experiencing controlled blood sugar; abrupt cessation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember that this medication complements a comprehensive diabetes management plan, incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifesting as sweating, dizziness, headache, and tremors. Recognize these symptoms and have readily available fast-acting glucose, like sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Patients with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals must consult their doctor before use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glimytime MV 1mg/500mg/0.2mg Tablet

There is no text provided to rephrase.

Uses of Glimytime MV 1mg/500mg/0.2mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimytime MV 1mg/500mg/0.2mg Tablet:

Your physician will determine the correct dosage and treatment length for Glimytime MV 1mg/500mg/0.2mg Tablets. Ingest each tablet whole; do not break, crush, or chew. Administer on an empty stomach.

Common Side effects of Glimytime MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimytime MV 1mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimytime MV 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.

How Glimytime MV 1mg/500mg/0.2mg Tablet works:

Each Glimytime MV tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimytime MV 1mg/500mg/0.2mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimytime MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Glimytime MV 1mg/500mg/0.2mg tablets is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glimytime MV 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Glimytime MV 1mg/500mg/0.2mg Tablets is discouraged for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Glimytime MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimytime MV 1mg/500mg/0.2mg Tablet :

Should you forget to take your Glimytime MV 1mg/500mg/0.2mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimytime MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimytime MV 1mg/500mg/0.2mg Tablet

Glimytime MV 1mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is not suitable for type 1 diabetes.
Glimytime MV 1mg/500mg/0.2mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infections.
Glimytime MV 1mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any ingredient. Avoid use in those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glimytime MV 1mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimytime MV 1mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), leading to symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimytime MV 1mg/500mg/0....
73
MRP 85
13% off